Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UDP-N-acetylmuramoyl-L-alanine--D-glutamate ligase (MurD) is a cytoplasmic enzyme essential for bacterial cell wall biosynthesis. It catalyzes the addition of D-glutamate to UDP-N-acetylmuramoyl-L-alanine, forming part of the peptidoglycan precursor pathway. This step is crucial for bacterial cell wall integrity, making it a validated target for antibacterial drug development.
Inhibition of peptidoglycan biosynthesis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on UDP-N-acetylmuramoyl-L-alanine--D-glutamate ligase (MurD).